This episode of MedTech Global Insights delves into the rigorous clinical evaluation requirements for Software as a Medical Device (SaMD) under the European Union's Medical Device Regulation (MDR). We unpack the critical guidance from MDCG 2020-1, breaking down the three essential pillars of evidence required for your Clinical Evaluation Report: scientific validity, analytical validity, and clinical performance. We explore how the MDR elevates the burden of proof for software, moving it beyond simple verification and validation to demand robust clinical data. This shift presents a significant hurdle for manufacturers accustomed to the old directive, where clinical evidence requirements were often less stringent. Failing to meet these new standards can lead to costly delays and outright rejection by Notified Bodies, halting market access. **Case Study:** Imagine a US-based startup with a revolutionary AI tool for detecting early-stage skin cancer. They have stellar US clinical data and a flawless algorithm but face a complete standstill at the EU border. Their Notified Body rejects their technical file, citing insufficient clinical evidence for the diverse European population, forcing them back to the drawing board for a multi-million dollar prospective study. This is a common and costly mistake that can derail a product launch. **What You'll Learn:** - What are the three core pillars of a SaMD clinical evaluation? - Why is your software's scientific basis just as important as its code? - How is 'analytical validity' different from traditional software verification and validation? - What kind of clinical performance data will a Notified Body actually accept? - Why is US or single-country clinical data often not enough for an EU submission? - What are the key takeaways from the MDCG 2020-1 guidance document? - How can you generate sufficient evidence without conducting a full-blown new clinical trial? - What are the most common pitfalls that lead to the rejection of a SaMD CER? For more information, contact us at [email protected] or visit https://pureglobal.com/.